Nigericin-induced IL-1β release from PBMCs from all patients with asthma (severe and non-severe combined, as there was no difference in nigericin-induced IL-1β between these) was significantly increased compared to healthy subjects (Additional file 1: Tables S1 and S2, Fig. 2A, B). The gene discussed is IL1B; the disease is asthma.